Precision Medicine Group Holdings, Inc. — Form D/A
Precision Medicine Group Holdings, Inc. of BETHESDA, MD, a company, filed a Form D amendment with the SEC on 2020-03-05. $84.7M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2020-03-05
- Form: D/A
- Accession: 0001732481-20-000002
- Industry: Other Health Care
- Exemptions: 06b
- Amount sold: $84.7M
- Investors: 75
- Date of first sale: 2018-02-16
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-306611
Issuer
- Name: Precision Medicine Group Holdings, Inc.
- CIK: 0001732481
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2016
- Address: 2 BETHESDA METRO CENTER, SUITE 850, BETHESDA, MD, 20814
- Phone: 240-654-0730
Officers, directors & promoters (14)
| Name | Role | Location |
|---|
| Mark Clein | Director | Bethesda, MD |
| Martin J Coulter | Director | Bethesda, MD |
| Christopher J Hadley | Director | Boston, MA |
| Matthew J Hobart | Director | Bethesda, MD |
| Annie J Lamont | Director | Bethesda, MD |
| Ethan Leder | Director | Bethesda, MD |
| Benjamin D Levy | Director | Boston, MA |
| Paul J Vigano | Director | Bethesda, MD |
| Charles T Clark | Executive Officer | Bethesda, MD |
| Mark Clein | Executive Officer | Bethesda, MD |
| Jesse T Glossner | Executive Officer | Bethesda, MD |
| Ethan Leder | Executive Officer | Bethesda, MD |
| John B Mariano, Jr. | Executive Officer | Bethesda, MD |
| Brent J Gunderson | Director | Bethesda, MD |
Other filings by this issuer (2)
More